Phase 1 PK, bioavailability, safety study of clonidine MBT w catapres in healthy volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to determine the pharmacokinetic dose proportionality of 50 μg and 100 μg Clonidine and comparative bioavailability of clonidine with that from the Reference drug, Catapres® 100 μg oral tablets following single dose administration in healthy subjects.
Epistemonikos ID: f3d09499cf4838c6a40ed90f970676a5a44a764a
First added on: May 12, 2024